vimarsana.com
Latest Breaking News On - Prnewswire artax biopharma inc - Page 1 : vimarsana.com
Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158
/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces.
Cambridge
Cambridgeshire
United-kingdom
Boston
Massachusetts
United-states
Artax-biopharma
Jamesg-krueger
Rob-armstrong
Company-phase
Linkedin
Advent-life-sciences
Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company's First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases
/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today.
Cambridge
Cambridgeshire
United-kingdom
Joseph-lobacki
Clinical-development-efforts
Prnewswire-artax-biopharma-inc
Findings-demonstrated
Investigational-agent
Well-tolerated
All-doses
Strongly-supports-further-clinical-development
Being-developed
Artax Biopharma Appoints Andre Hoekema, Ph.D., to Company's Board of Directors
/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today.
Cambridge
Cambridgeshire
United-kingdom
Canada
Netherlands
Holland
Andre-hoekema
Artax-biopharma
Joseph-lobacki
Company-board-of-directors
Genentech-inc
Leiden-university
Artax Biopharma Expands Company's Scientific Advisory Board
/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today.
Stanford-university
California
United-states
Boston
Massachusetts
San-diego
Cambridge
Cambridgeshire
United-kingdom
Spain
Amsterdam
Noord-holland
vimarsana © 2020. All Rights Reserved.